• Anaveon AG

    BS
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-280.3.021.839-0
    Sector: Research and development

    Age of the company

    7 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    20'229

    Employees

    PremiumPremium

    Active brands

    4

    Reports for Anaveon AG

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Shareholder Information

    Find out which national and international companies the stock corporation you are interested in also holds shares in.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Anaveon AG

    • Anaveon AG is currently active and the industry «Research and development». The legal headquarters are in Basel.
    • The company was founded on 11.12.2017 and has 14 persons in its management.
    • On the 10.07.2025 the commercial register entry of the company was last changed. Under «Notifications» you will find all changes.
    • In the commercial register the company Anaveon AG is registered under the UID CHE-232.476.299.
    • 4 trademarks or applications for trademarks of the company Anaveon AG are registered at the IPI.
    • ADVESYA AG, AlloCyte Pharmaceuticals AG, ARTIDIS AG are registered at the same address.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und den Vertrieb von pharmazeutischen und diagnostischen Produkten. Die Gesellschaft kann sich daneben an anderen Unternehmen irgendwelcher Art im In- und Ausland beteiligen, solche gründen, übernehmen und mit ihnen fusionieren. Sie kann Liegenschaften und Immaterialgüterrechte im In- und Ausland erwerben, belasten und veräussern sowie durch Beschluss des Verwaltungsrates Zweigniederlassungen und Agenturen im In- oder Ausland errichten.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Ernst & Young AG
    Basel 18.06.2020

    Would you like to adjust the auditors? Click here.

    Former auditor (1)
    Name City Since Until
    Balance Audit AG
    Basel 04.03.2019 17.06.2020

    Other company names

    Source: SOGC

    Past and translated company names

    • Anaveon SA
    • Anaveon Ltd
    Would you like to update the company name? Click here.

    Branches (1)

    Anaveon AG in Basel

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Trademarks

    Source: Swissreg
    Trademark Registration date Status Number
    to the trademark 26.04.2021 active 17109/2020
    26.04.2021 active 17109/2020

    Newest SOGC notifications: Anaveon AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250710/2025 - 10.07.2025
    Categories: Change in capital

    Publication number: HR02-1006380854, Commercial Registry Office Basel-Stadt, (270)

    Anaveon AG, in Basel, CHE-232.476.299, Aktiengesellschaft (SHAB Nr. 54 vom 19.03.2025, Publ. 1006286005).

    Statutenänderung:
    26.06.2025.

    Partizipationskapital neu:
    CHF 13'543.00 [bisher: CHF 6'686.00].

    Liberierung Partizipationskapital neu:
    CHF 13'543.00 [bisher: CHF 6'686.00].

    Partizipationsscheine neu:
    13'543 Namen-Partizipationsscheine zu CHF 1.00 [bisher: 6'686 Namen-Partizipationsscheine zu CHF 1.00]. Kapitalerhöhung aus bedingtem Partizipationsscheinkapital.

    SOGC 250319/2025 - 19.03.2025
    Categories: Change in management

    Publication number: HR02-1006286005, Commercial Registry Office Basel-Stadt, (270)

    Anaveon AG, in Basel, CHE-232.476.299, Aktiengesellschaft (SHAB Nr. 8 vom 14.01.2025, Publ. 1006227524).

    Ausgeschiedene Personen und erloschene Unterschriften:
    Gasal, Eduard, von Cham, in Zürich, mit Kollektivunterschrift zu zweien.

    Eingetragene Personen neu oder mutierend:
    Sachse, Dr. Richard, deutscher Staatsangehöriger, in Allschwil, mit Kollektivunterschrift zu zweien.

    SOGC 250114/2025 - 14.01.2025
    Categories: Change in management

    Publication number: HR02-1006227524, Commercial Registry Office Basel-Stadt, (270)

    Anaveon AG, in Basel, CHE-232.476.299, Aktiengesellschaft (SHAB Nr. 123 vom 27.06.2024, Publ. 1006068900).

    Eingetragene Personen neu oder mutierend:
    Weinand, Dieter, amerikanischer Staatsangehöriger, in Palm Beach Shores (FL) (US), Präsident des Verwaltungsrates, mit Kollektivunterschrift zu zweien;
    Patrick, Denis, amerikanischer Staatsangehöriger, in New York City (US), Mitglied des Verwaltungsrates, mit Kollektivunterschrift zu zweien [bisher: Präsident des Verwaltungsrates, mit Kollektivunterschrift zu zweien].

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm